Patient Guide: A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 18 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04024462
Status: ACTIVE_NOT_RECRUITING
Condition: HER2-positive Early Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 18 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing,
  • Beijing,
  • Changchun,
  • • And 15 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily